FindTrial
Sign In

Decrease per-dialytic heparin therapy

DEVICE2 trials

Sponsors

CHU de Reims

Conditions

Anticoagulants / Administration & DosageBiocompatibleChronic HemolysisCoated MaterialsHeparin / Administration & DosageMembranes ArtificialProspective StudiesRenal Dialysis / Methods

Unknown Phase

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA
NCT04462614
CHU de ReimsAnticoagulants / Administration & Dosage, Biocompatible, Chronic Hemolysis +7
Start: 2020-08-31End: 2021-07-31Target: 49Updated: 2020-07-08
Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients
RecruitingNCT05117450
CHU de ReimsRenal Insufficiency
Start: 2021-11-17End: 2026-12-17Target: 302Updated: 2025-11-21

Related Papers

Évaluation de la faisabilité du sevrage héparinique durant les séances d’hémodialyse chez des patients sous AVK avec la membrane HeprAN
Néphrologie & Thérapeutique2022-09-01